* Repligen Corp RGEN.OQ RGEN.O is expected to show a
fall in
quarterly revenue when it reports results on August 2.
* The Waltham Massachusetts-based company is expected to
report
a 20.1% decrease in revenue to $165.922 million from $207.63
million a year ago, according to the mean estimate from 13
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Repligen Corp is
for
earnings of 48 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Repligen
Corp is
$194.5, above its last closing price of $174.22.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 0.59 0.59 0.64 Beat 9
Dec. 31 2023 0.57 0.58 0.68 Beat 17.8
Sep. 30 2022 0.68 0.68 0.77 Beat 13.2
Jun. 30 2022 0.72 0.72 0.91 Beat 27
Mar. 0.72 0.72 0.92 Beat 27.8
31 2022
Dec. 31 2021 0.65 0.65 0.81 Beat 24.9
Sep. 30 2021 0.64 0.64 0.78 Beat 22.6
Jun. 30 2021 0.52 0.52 0.79 Beat 50.8
This summary was machine generated July 31 at 18:35 GMT. All
figures in US dollars unless otherwise stated